Nestle India is forming a joint venture with Dr. Reddy’s Laboratories to boost the reach of its nutraceutical products, such as Nature’s Bounty and Optifast, across India.
The report comes a day after Novartis AG announced a strategic review of its India arm. The strategic review, the firm, said includes an assessment of the 70.68 per cent shareholding of Novartis AG in the company.
As the market for anti-obesity drugs in India grows rapidly, pharma majors like Dr. Reddy's, Zydus, and Sun Pharma are competing to quickly enter the market with weight-loss drugs - Issue Date: Jan 07, 2024